Cross-reactive anti-PfCLAG9 antibodies in the sera of asymptomatic parasite carriers of Plasmodium vivaxv
The PfCLAG9 has been extensively studied because their immunogenicity. Thereby, the gene product is important for therapeutics interventions and a potential vaccine candidate. Antibodies against synthetic peptides corresponding to selected sequences of the Plasmodium falciparum antigen PfCLAG9 were...
Saved in:
Published in: | Memórias do Instituto Oswaldo Cruz Vol. 108; no. 1 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Fundação Oswaldo Cruz, Fiocruz
13-03-2013
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The PfCLAG9 has been extensively studied because their immunogenicity.
Thereby, the gene product is important for therapeutics interventions
and a potential vaccine candidate. Antibodies against synthetic
peptides corresponding to selected sequences of the Plasmodium
falciparum antigen PfCLAG9 were found in sera of falciparum malaria
patients from Rondônia, in the Brazilian Amazon. Much higher
antibody titres were found in semi-immune and immune asymptomatic
parasite carriers than in subjects suffering clinical infections,
corroborating original findings in Papua Guinea. However, sera of
Plasmodium vivax patients from the same Amazon area, in particular
from asymptomatic vivax parasite carriers, reacted strongly with the
same peptides. Bioinformatic analyses revealed regions of similarity
between P. falciparum Pfclag9 and the P. vivax ortholog Pvclag7.
Indirect fluorescent microscopy analysis showed that antibodies against
PfCLAG9 peptides elicited in BALB/c mice react with human red blood
cells (RBCs) infected with both P. falciparum and P. vivax parasites.
The patterns of reactivity on the surface of the parasitised RBCs are
very similar. The present observations support previous findings that
PfClaglag 9 may be a target of protective immune responses and raises
the possibility that the cross reactive antibodies to PvCLAG7 in mixed
infections play a role in regulate the fate of Plasmodium mixed
infections. |
---|---|
ISSN: | 1678-8060 |